Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Agid

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
The American Journal of Psychiatry|July 31, 2013
Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010Ofer Agid, Cynthia O Siu, Steven G Potkin, et al.
Journal of Psychiatric Research|November 10, 2020
Exploring the relationship between impaired illness awareness and visuospatial inattention in patients with schizophreniaKyle Daniell, Julia Kim, Yusuke Iwata, et al.
Schizophrenia Research|November 26, 2018
Goal-directed planning and action impairments in schizophrenia evaluated in a virtual environmentIshraq Siddiqui, Sarah Saperia, Gagan Fervaha, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2008
The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET studyAriel Graff-Guerrero, Romina Mizrahi, Ofer Agid, et al.
NPJ Schizophrenia|January 9, 2020
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future researchSteven G Potkin, John M Kane, Christoph U Correll, et al.
Focus (American Psychiatric Publishing)|December 21, 2020
The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future ResearchSteven G Potkin, John M Kane, Christoph U Correll, et al.
Expert Review of Neurotherapeutics|March 31, 2025
Current perspectives on the recognition and management of treatment-resistant schizophrenia: challenges and opportunitiesMyrto Samara, Georgios Alevizopoulos, Vasilis P Bozikas, et al.
The American Journal of Psychiatry|September 1, 2004
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychoticsJohannes Tauscher, Tabasum Hussain, Ofer Agid, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Clinical Guidance on the Identification and Management of Treatment-Resistant SchizophreniaJohn M Kane, Ofer Agid, Marjorie L Baldwin, et al.
Schizophrenia Research|November 17, 2018
Reward-driven decision-making impairments in schizophreniaSarah Saperia, Susana Da Silva, Ishraq Siddiqui, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
The American Journal of Psychiatry|July 31, 2013
Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010Ofer Agid, Cynthia O Siu, Steven G Potkin, et al.
Journal of Psychiatric Research|November 10, 2020
Exploring the relationship between impaired illness awareness and visuospatial inattention in patients with schizophreniaKyle Daniell, Julia Kim, Yusuke Iwata, et al.
Schizophrenia Research|November 26, 2018
Goal-directed planning and action impairments in schizophrenia evaluated in a virtual environmentIshraq Siddiqui, Sarah Saperia, Gagan Fervaha, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2008
The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET studyAriel Graff-Guerrero, Romina Mizrahi, Ofer Agid, et al.
NPJ Schizophrenia|January 9, 2020
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future researchSteven G Potkin, John M Kane, Christoph U Correll, et al.
Focus (American Psychiatric Publishing)|December 21, 2020
The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future ResearchSteven G Potkin, John M Kane, Christoph U Correll, et al.
Expert Review of Neurotherapeutics|March 31, 2025
Current perspectives on the recognition and management of treatment-resistant schizophrenia: challenges and opportunitiesMyrto Samara, Georgios Alevizopoulos, Vasilis P Bozikas, et al.
The American Journal of Psychiatry|September 1, 2004
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychoticsJohannes Tauscher, Tabasum Hussain, Ofer Agid, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Clinical Guidance on the Identification and Management of Treatment-Resistant SchizophreniaJohn M Kane, Ofer Agid, Marjorie L Baldwin, et al.
Schizophrenia Research|November 17, 2018
Reward-driven decision-making impairments in schizophreniaSarah Saperia, Susana Da Silva, Ishraq Siddiqui, et al.
Pageof 13